Bar Harbor BioTechnology Gains PCR and Real-Time PCR Patents from Life Technologies
Bar Harbor BioTechnology (BHB) has entered into a license agreement with Life Technologies to offer contract research services related to data collection and analysis based on the StellARray™ and XenoQ™ systems.
“We wanted to make our expertise in assay design available to all genetic researchers and provide excellent quality data,” states Robert Phelps, CEO of BHB. Researchers purchasing StellARrays or XenoQ assays through Lonza, their exclusive distributor, can now contract BHB to perform real-time PCR services.
The data generated in the experiments will be analyzed using BHB’s Global Pattern Recognition™ analysis software. The company has expanded its staff to provide the new services secured in this agreement.